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Abstract 26 
The prolyl-4-hydroxylase domain (PHD) enzymes are regarded as the molecular oxygen 27 
sensors. There is an interplay between oxygen availability and cellular metabolism, which in 28 
turn has significant effects on the functionality of innate immune cells like macrophages. If 29 
and how PHDs affect macrophage metabolism however is enigmatic. We hypothesized that 30 
via manipulation of PHD2 macrophage metabolism and function can be controlled. We 31 
characterized the metabolic phenotype of PHD2-deficient RAW cells and primary PHD2 32 
knock out bone marrow derived macrophages (BMDM). Both showed typical features of 33 
anaerobic glycolysis, which were paralleled by increased pyruvate dehydrogenase kinase 34 
(PDK)1 protein levels and a decreased pyruvate dehydrogenase enzyme activity. Metabolic 35 
alterations were associated to an impaired cellular functionality. Inhibition of PDK1 or knock 36 
out of the Hypoxia inducible factor (HIF)-1α reversed the metabolic phenotype and impaired 37 
functionality of the PHD2-deficient RAW cells and BMDM. Taken together we identified a 38 
critical role of PHD2 for a reversible glycolytic reprogramming in macrophages with a direct 39 
impact on their function. We suggest that PHD2 serves as an adjustable switch to control 40 
macrophage behavior.      41 
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Introduction 42 
Macrophages are an essential component of innate immunity and well recognized to play a 43 
critical role in inflammation, tumor progression and tissue repair for example after an 44 
ischemic insult (1). In aerobic conditions the oxidative breakdown of pyruvate within the 45 
mitochondria is the prevalent source of energy in most cells. Upon a decrease in oxygen 46 
availability cells shift the metabolism towards anaerobic glycolysis. In line, macrophages can 47 
use aerobic or anaerobic glycolysis for energy production depending on the context. There is 48 
growing understanding that macrophage function can be altered by cellular metabolism (2). 49 
One of the key factors at the transcriptional level in switching aerobic to anaerobic 50 
metabolism is the hypoxia-inducible factor (HIF). HIF comprises two subunits, i.e. the 51 
constitutively regulated HIFβ subunit and one of three oxygen-regulated HIFα subunits (HIF-52 
1α, HIF-2α or HIF-3α) (3). The protein stability of HIFα is regulated by the three prolyl-4-53 
hydroxylase domain (PHD) enzymes PHD1, 2 and 3, which hydroxylate HIFα in an oxygen-54 
dependent manner (for review (4,5)). The hydroxylated product is recognized by the pVHL 55 
protein, which results in ubiquitination and proteasomal degradation of the α-subunit. In 56 
hypoxia the hydroxylation and degradation is inhibited and thus HIFα is stabilized, which 57 
finally results in HIF-dependent transcriptional activation of a repertoire of target genes. 58 
Besides many others, glycolytic enzymes and the pyruvate dehydrogenase kinase 1 (PDK1) 59 
belong to the target genes (6,7). Both determine the glycolytic cellular program. PHD 60 
enzymes are of interest for the ongoing development of small molecule inhibitors, which 61 
would allow stimulating HIF-dependent gene expression in normoxia (8).  62 
PHD1-3 have common but also non redundant functions (9). In case of innate immunity the 63 
role of PHD3 has been analyzed in detail (10-12). The role of PHD2 however is less 64 
understood. Especially, if and how PHD2 affects macrophage metabolism has not been 65 
described before. We therefore analyzed the consequences of a knock out of PHD2 in bone 66 
marrow derived macrophages (BMDM) isolated from LysM Cre+/- x Phd2fl/fl  (named 67 
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conditional knock out, PHD2 cKO in the following text) mice and the monocyte/macrophage 68 
cell line RAW264 for their cell metabolism and function. 69 
  70 
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Materials and Methods 71 
Chemicals 72 
The oxoglutarate analogue dimethyloxalylglycine (DMOG, Enzo) and the PDK inhibitor 73 
dichloroacetate (DCA, Sigma) were used in final concentrations of 1 mM and 5 mM, 74 
respectively. LPS (Enzo Life Sciences, Lörrach, Germany), IFN and IL-4 (Peprotech, 75 
Hamburg, Germany) were applied in a concentration of 100 ng/mL, 20 nM and 20 nM, 76 
respectively or as indicated. 77 
 78 
Myeloid-specific conditional knock out mice  79 
All animals in this study were backcrossed to C57BL/6 mice at least five times. Phd2flox/flox x 80 
LysMcre+/- mice were crossed with Phd2flox/flox mice to obtain PHD2 cKO (Phd2flox/flox x 81 
LysMcre+/-) mice and littermate control wild type mice (Phd2flox/flox).  Generation of 82 
Phd3flox/flox x LysMcre+/- (PHD3 cko) mice is described in (12). To obtain PHD2/HIF-1α 83 
double knock out macrophages Phd2flox/flox x LysMcre+/- were crossed with Hif-1αflox/flox mice 84 
(B6.129-Hif1atm3Rsjo/J, Jackson Laboratories) to obtain PHD2flox/flox x HIF-1αflox/flox x 85 
LysMcre+/- mice (dcKO).   86 
 87 
Isolation and differentiation of BMDM 88 
Bone marrow cells were isolated from the femur. After 24 h of culturing the cells non 89 
adherent monocytes were harvested and seeded in Pluznik´s medium (DMEM supplemented 90 
with 0.2 mM L-glutamine, 0.1 mM sodium pyruvate, 50 U/mL penicillin G, 50 μg/mL 91 
streptomycin, 10% heat-inactivated fetal calf serum, 5% heat-inactivated horse serum (Pan 92 
Biotech, Aidenbach, Germany), 0.05% 1:1000 diluted ß-mercaptoethanol (Carl Roth GmbH, 93 
Karlsruhe, Germany), and 15% L929 cell-conditioned medium (13)) and differentiated for 7 94 
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days. Adherent bone marrow-derived macrophages (BMDM) were detached with 3.5 mL 95 
accutase (PAA Laboratories, Cölbe, Germany) and resuspended in culture medium (DMEM 96 
supplemented with, 0.2 mM L-glutamine, 0.1 mM sodium pyruvate, 1 mM HEPES, 50 U/mL 97 
penicillin G, 50 μg/mL streptomycin and 10% heat-inactivated fetal calf serum). For 98 
analyzing lactate production without addition of glucose, glucose-free medium (Pan Biotech) 99 
was used as indicated. Successful differentiation of the BMDM was controlled by FACS-100 
staining for the macrophage marker F4/80.  101 
 102 
Generation of shPHD2 RAW cells 103 
The mouse macrophage cell line RAW 264.7 was infected with Lentivirus encoding shRNA 104 
targeting mPHD2 (5’-ATTCGAAGAATACCTCCAC-3’) and cotransfected with EGFP as 105 
described earlier (14). Cells were used as a pool of sorted EGFP+ cells and knock-down 106 
efficiency was tested via qPCR. 107 
 108 
Preparation of MDA-MB231 conditioned medium 109 
5 flasks each with 1x106 MDA-MB231 cells were cultivated in 15 ml culture medium for 4 110 
days. The medium was transferred to a reaction tube and centrifuged at 4000 g for 20 min at 4 111 
ºC. The supernatant was pooled and frozen at -80 ºC. 112 
 113 
Hypoxic incubation 114 
For culturing cells in defined hypoxic conditions (1% O2) an invivo Hypoxia workstation was 115 
used (Ruskinn Technologies).  116 
 117 
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Phagocytosis 118 
Fluorescent beads (ProtonexTM Red 600-Latex Beads, AAT Bioquest, Sunnyvale, USA) were 119 
administered to cells for 4 h. After washing, uptake of fluorescent beads was analyzed by 120 
FACS (BD FACS Canto II, BD Biosciences).  121 
 122 
Quantification of apoptotic cells 123 
Supernatant and detached cells were collected. Samples were centrifuged and washed in PBS. 124 
Subsequently, cells were stained for 30 min at 4°C with Pacific Blue Annexin V (70 µg/ml) 125 
per sample (640918, Biolegend, San Diego, USA) diluted 1:150 in the dark. Samples were 126 
washed in Annexin V binding buffer (422201, Biolegend) and analyzed by FACS (BD FACS 127 
Canto II, BD Biosciences). 128 
 129 
Single cell migration 130 
2.5 x 104 RAW cells or 5 x 104 BMDMs were seeded in a 6-well plate. The next day the 131 
medium was replaced with either normal medium or MDA-MB231 conditioned medium. The 132 
migration of the cells was investigated using the T1-5M Nikon microscope inside the Sci-tive 133 
work station (Ruskinn, Bridgend, South Wales) at normoxic (20% O2) or hypoxic (1% O2) 134 
conditions. An image was taken every 10 min for in total 6 h. The migration was analyzed 135 
using the chemotaxis plug-in installed in ImageJ.  136 
 137 
 138 
 139 
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Boyden chamber assay 140 
0.7 x 105 BMDM or RAW cells were seeded in 500 µL culture medium into inserts (BD 141 
Biosciences, Heidelberg, Germany) containing 3 µm pores. Inserts were placed into 24-well 142 
plates containing either 500 µl MDA-MB 231 conditioned medium or 500 µL cell culture 143 
medium as control. 18 h later inserts were placed into medium with 5 µM calcein. Cells that 144 
had not migrated were removed by scraping of the upper side of the insert after 1 h, while 145 
migrated macrophages on the lower side were analyzed by fluorescence microscopy (Axio 146 
Observer D1, Carl Zeiss, Göttingen, Germany).  147 
 148 
RNA isolation and qRT PCR 149 
Cells were washed once with PBS and harvested in Trizol (Invitrogen, Darmstadt, Germany). 150 
RNA was isolated according to the manufacturer’s instructions and 1 µg was transcribed 151 
using the First Strand cDNA Synthesis Kit (Fermentas, St. Leon-Rot, Germany). Transcript 152 
levels were analyzed by qRT PCR amplifying 1 µL of cDNA with Brilliant II SYBR Green 153 
qPCR Master Mix in an MX3005Pro light cycler (Agilent, Böblingen, Germany). Applied 154 
primer sequences were: ms12 for 5´-GAAGCTGCCAAGGCCTTAGA -3´, rev 5´-155 
AACTGCAACCAACCACCTTC-3´; phd2 for  5´-TTGCTGACATTGAACCCAAA-3´, 156 
rev 5´-GGCAACTGAGAGGCTGTAGG-3´; phd3 for 5´-GGCCGCTGTATCACCTGTAT-157 
3´, rev 5´-TTCTGCCCTTTCTTCAGCAT -3´; glut1 for 5´-158 
TGGCCTTGCTGGAACGGCTG-3´, rev 5´-TCCTTGGGCTGCAGGGAGCA -3´; pfk1 for 159 
 5´-ACGAGGCCATCCAGCTCCGT-3´, rev 5´-160 
TGGGGCTTGGGCAGTGTCCT -3´; pdk1 for 5´-TTCACGTCACGCTGGGCGAG -3´, rev161 
 5´-GGCTGGGCACACACCAGTCG -3´; cox4.2for 5´-162 
CAGAGAAGGTGGCCTTGTACC -3´, rev 5´-AGAAGAAGACGCAGCCCATC -3´; LonP163 
  for 5´-CATCGCCTTGAACCCTCTGT-3´, rev  5´-164 
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AGCCGCTTAAGGATGTTGGT-3´; BNIP3 for 5´-GTCCAGTGTCGCCTGGCCTC -3´, 5´-165 
TGGGAGCGAGGTGGGCTGTC -3´, mCCR2 for 5´-CCACACCCTGTTTCGCTG-3´, 166 
mCCR2 rev 5´-ACCTCTTCAGCACTTGC-3´; mCCR4 for 167 
5´-GCCTCTTGTTCAGCACTTGC-3´, mCCR4 rev 5´-ATAAGCAGCCCCAGGACG-3´;  168 
mCCR5 for 5´-CCAGAGGAGGTGAGACATCCGTTC-3´, mCCR5 rev 5´-169 
GGCAGGAGCTGAGCCGCAATTT -3´; mCCR7 for 5´- 170 
ATGGACCCAGGGAAACCCAGGAA-3´, 171 
mCCR7 rev 5´-GCACACCGACTCGTACAGGG-3´; mCXCR4 for 5´-172 
GCTCCGGTAACCACCACGGC-3´, mCXCR4 rev 5´-GCGAGGTACCGGTCCAGGCT-3´. 173 
 174 
Microarray-Based Gene Expression 175 
Microarray-based gene expression was analysed as described before (12). 176 
 177 
Western blots 178 
Cells were lysed with 50 mM Tris, 150 mM NaCl, 0.5 mM PMSF, 100 mM MgCl2, 1% NP-179 
40 supplemented with protease inhibitors (Roche). Protein samples were resolved by SDS-180 
PAGE and transferred onto nitrocellulose membranes (Amersham Biosciences). Primary 181 
antibodies used were: anti-HIF-1α (NB-100-479, Novus), anti-HIF-2α (AF2997, R&D 182 
Systems), anti-PHD2 (NB-100-2219, Novus), anti-phospho pyruvate dehydrogenase 183 
(ABS204, Merck), anti-pyruvate dehydrogenase (3205, Cell Signaling), anti-PDK1 (ADI-184 
KAP-PK112-D, Stressgene), and anti-β-actin (A5441, Sigma). For detection of 185 
immunocomplexes horseradish peroxidase-conjugated secondary goat anti-rabbit or goat anti-186 
mouse antibodies (Santa Cruz Biotechnology) were used and membranes were incubated with 187 
chemilumiescent HRP substrate (Millipore). 188 
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ATP and lactate measurements 189 
Supernatant of 0.75 x 105 BMDM  or RAW cells cultivated for 24 h in 24-well plates was 190 
analyzed for lactate production using a l-lactate kit according to the manufacturer’s 191 
instructions (R-Biopharm, Darmstadt, Germany). For determination of ATP levels 0.2 x 105 192 
BMDM or RAW cells were seeded. ATP levels were determined using the Cell titer-Glo ATP 193 
kit (Promega, Madison, USA).   194 
 195 
PDH activity assay 196 
For determining PDH activity, the MAK183 kit (Sigma, St. Louis, USA) was used. 197 
 198 
Oxygen consumption rate and extracellular acidification rate 199 
Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were analyzed 200 
in the Seahorse XF96 extracellular flux analyzer (Seahorse Bioscience, Billerica, MA, USA). 201 
For OCR 2.5 x 104 RAW or 4.0 x 104 BMDM cells per well were seeded. The medium was 202 
replaced with XF assay medium supplemented with 4.5 g/L glucose and 1 mM sodium 203 
pyruvate and incubated without CO2 for 30 min. After measuring basal respiration, the 204 
oxygen consumption was analyzed after sequential addition of 1.5 µM oligomycin, 1 µM 205 
FCCP, 2 µM rotenone and 1 µM antimycin A.  206 
For determining the ECAR, 2.5 x 104 (RAW) or 8 x 104 (BMDM) cells per well were seeded. 207 
Cells were washed with XF Glycostress-medium (DMEM D 5030, 134 mM NaCl, 3 mg 208 
Phenol Red, 2 mM L-glutamine, pH 7.35). The cells were incubated for 15 min at 37ºC 209 
without CO2. ECAR was analyzed after sequential addition of 10 mM glucose, 1.5-3 µM 210 
oligomycin, and 100 mM 2-deoxy-glucose (2-DG). 211 
 212 
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Statistical analyses 213 
Statistical analyses were performed using Student`s two-tailed t-test. Data are shown as 214 
means ± SEM. Values of p < 0.05 were considered statistically significant. 215 
 216 
  217 
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Results 218 
PHD2-deficient macrophages induce a hypoxic gene expression pattern in normoxia 219 
including PDK1, a central regulator of the pyruvate dehydrogenase 220 
BMDM isolated from PHD2fl/fl x LysMCre mice (PHD2 cKO) and RAW cells, which were 221 
transfected with a constitutively active shRNA targeting PHD2 (shPHD2) showed an 80% 222 
reduction of PHD2 RNA with a consequential increase of PHD3 RNA expression compared 223 
to wt BMDM and wt RAW cells (Fig. 1A). The compensatory increase of the HIF-1 target 224 
gene PHD3 is in line with other cell/tissue-specific PHD2 knock out mouse models (15). 225 
Besides PHD3 other metabolism-related HIF target genes like Glut-1, PFK1, PDK1, COX4-2, 226 
LonP and BNIP3 were upregulated. The gene expression pattern of the PHD2 cKO and 227 
shPHD2 cells resembled the pattern of HIF target genes in wt BMDMs and wt RAW cells 228 
after incubation in hypoxia. In quantitative means, however the levels of the HIF target genes 229 
were lower in the shPHD2 and PHD2 cKO cells in normoxia compared to the respective wt 230 
cells in hypoxia, which indicates that the reduction of PHD2 induced a partial HIF-response 231 
possibly due to the fact that the other PHDs, i.e. PHD1 and PHD3 are still active. This 232 
assumption was further supported by the fact that after hypoxic incubation of shPHD2 and 233 
PHD2 cKO cells the RNA levels of the HIF target genes were further increased to a similar 234 
extent as the respective wt cells in hypoxia. Cell viability/cell death, as determined by the 235 
number of AV single-positive cells, were not different in untreated wt BMDM and wt RAW 236 
cells compared to PHD2 cKO and shPHD2, respectively or after treatment with 1 mM 237 
DMOG (Fig. 1B).   238 
 PHD2 protein levels were decreased in PHD2 cKO and shPHD2 cells likewise (Fig. 239 
1C). Whereas HIF-1 and HIF-2α were detectable in BMDM isolated from wt mice in 240 
hypoxia only, PHD2 cKO BMDM revealed high HIF-1 and HIF-2α protein levels in 241 
normoxia. In the RAW cells HIF-2α was not detectable with the antibodies applied. For HIF-242 
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1α a similar pattern as in the BMDM was observed. Comparable to the HIF target RNA 243 
expression HIF-1α and HIF-2α protein levels were further increased after exposing the PHD2 244 
cKO cells and shPHD2 RAW cells to hypoxia. Taken together this demonstrates a 245 
biologically relevant reduction of PHD2 with subsequent stabilization of the HIF- proteins 246 
and induction of HIF target genes like PDK1 in the cell line model and the genetically 247 
modified primary macrophages partially mimicking hypoxia. The increased expression of 248 
PDK1 was further analyzed at protein level. PDK1 is a major regulator in central metabolic 249 
pathways including glucose consumption. It acts in part by regulating the activity of the 250 
pyruvate dehydrogenase (PDH) by phosphorylation, which results in inactivation of the 251 
enzyme. PDH is one part of a mitochondrial multi-enzyme complex that catalyzes the 252 
oxidative decarboxylation of pyruvate and is one of the major enzymes responsible for the 253 
regulation of homeostasis of carbohydrate fuels in mammals. The induction of PDK1 in the 254 
PHD2-deficient cells in normoxia was also detectable at the protein level (Fig. 1D). In line, 255 
PDH was found to be more phosphorylated in the shPHD2 RAW cell and the PHD2 cKO 256 
BMDM compared to their wild type cells. In hypoxia both, wt and the PHD2-deficient cells, 257 
showed increased PDK1 protein level and phosphorylation of PDH. In parallel we determined 258 
the PDH activity in cell extracts isolated from wt cells and PHD2-deficient cells after 259 
exposure to normoxia or hypoxia (Fig. 1E). shPHD2 cells exhibited a significantly lower 260 
PDH activity in normoxia, which was also observed in wt cells after treatment with the PHD 261 
inhibitor DMOG. In hypoxia, a decreased PDH activity was observed in wt and shPHD2 262 
cells, still with significantly lower levels in the knock down cells.  Since PDK1 is a critical 263 
regulator of cellular metabolism, we next analyzed the glycolytic capacity in the PHD2-264 
deficient cells. 265 
 266 
 267 
 268 
14 
 
PHD2-deficient macrophages show a switch to glycolytic metabolism 269 
Glycolysis utilization for energy demand can be characterized by the oxygen consumption 270 
and the extracellular acidification rate after stimulation. Basal oxygen consumption rate and 271 
maximal respiration after uncoupling the mitochondria with FCCP were significantly 272 
decreased in the PHD2-deficient cells or after treating wt cells with DMOG, which indicates 273 
that as a consequence of inhibiting PHD activity macrophages shift their source of energy to 274 
anaerobic glycolysis (Fig. 2A and B). This was further supported by a significantly increased 275 
glycolytic function as determined by the extracellular acidification rate after glucose or 276 
oligomycin treatment, which reflects basal glycolysis and the overall glycolytic capacity, 277 
respectively (Fig. 2C-F).  In line we found increased lactate levels in the supernatant of 278 
shPHD2 RAW cells and PHD2 cKO BMDM compared to their respective wt cells (Fig. 2G). 279 
Lactate levels were likewise increased after DMOG treatment or exposure of the cells to 280 
hypoxia. Incubating wt and PHD2 cKO BMDM without glucose at 20% O2 abolished the 281 
lactate production demonstrating that the glucose in the culture medium is indeed the major 282 
source for lactate production (Fig. 2H). 283 
 A fully operative cellular metabolism of macrophages is important to provide the 284 
necessary amount of ATP. Aerobic versus anaerobic glycolysis are differing in the net 285 
production of ATP. In line with the less efficient anaerobic glycolysis, levels of ATP were 286 
significantly diminished in the PHD2 cKO BMDM, shPHD2 RAW cells as well as after 287 
treating RAW wt cells with DMOG or exposing them to hypoxia (Fig. 3A), which might 288 
impact their functionality namely polarization, migration and phagocytosis. Macrophages 289 
display remarkable plasticity and can change their phenotype upon stimulation (16). The most 290 
prominent macrophage populations are the M1- and M2-polarized macrophages. To analyze if 291 
the metabolic alterations in the PHD2-deficient cells affects macrophage polarization we 292 
analysed RNA levels of the M1 markers TNFα, iNOS, and MCP-1 as well as the the M2 293 
markers Ym1 and Fizz in wt and PHD2 cKO BMDM. Arginase, which is also a M2 marker, 294 
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was not detectable in non-stimulated wt BMDM. None of the M1 or M2 markers were 295 
changed in the PHD2 cKO BMDMs (Fig. 3B). Subsequently, we stimulated the cells with 296 
LPS and the Th1 cytokine IFN or the Th2 cytokine IL-4 to functionally characterize M1- and 297 
M2-polarization, respectively (Fig. 3C). Successful M1- and M2-polarization after stimulation 298 
was verified by increased RNA levels of TNFα, iNOS and MCP-1 after treatment with LPS as 299 
well as the Ym1, arginase and Fizz after treatment with IL-4. Expression levels of the M1 and 300 
M2-marker RNAs were not different comparing wild type and PHD2 cKO BMDM. A lack in 301 
macrophage polarization in the PHD2 cKO BMDM was additionally confirmed by a non-302 
biased RNA microarray gene expression assay (Suppl. Table 1 and Table 2). In total 42 genes 303 
were found to be significantly upregulated in PHD2 cKO BMDM including PHD3, BNIP3, 304 
PFK1, and PDK1 and 56 were found to be significantly downregulated. Pathway analysis of 305 
the RNAs identified to be up- or downregulated in the PHD2 cKO BMDM versus wt BMDM 306 
did not reveal any indications for a macrophage polarization. Likewise treatment of wt or 307 
PHD2 cKO BMDM with DMOG resulted in altered RNA expression but no clear pattern of 308 
M1 or M2 associated genes (Fig. 3D). Whereas DMOG resulted in significantly decreased 309 
RNA levels of TNFα and MCP1, iNOS, FIZZ and arginase were significantly increased in wt 310 
as well as cKO BMDM. Taken collectively, the metabolic alterations in consequence if 311 
DMOG treatment results in the downregulation of RNAs of some M1 associated genes, 312 
however no stringent impact on the polarization of macrophages was observed in cKO 313 
BMDM. 314 
 315 
Impaired migratory and phagocytic capacity of PHD2 cKO BMDM and shPHD2 RAW 316 
cells 317 
Whereas most cells in the body are fixed in place, macrophages are motile and able to migrate 318 
into surrounding tissues, where one of their major tasks is phagocytosis of invading pathogens 319 
or cell debris. We analyzed the migration capacity of the PHD2 cKO BMDM and shPHD2 320 
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RAW cells by confronting the macrophages with conditioned supernatant of the MDA-321 
MB231 breast carcinoma cells in a Boyden chamber and in single cell migration experiments. 322 
Significantly less PHD2 cKO BMDM and shPHD2 RAW cells migrated compared to their 323 
respective wt cells in the Boyden chamber (Fig. 4A). Additionally the accumulated distance 324 
in the single cell migration experiments was found to be reduced (Fig. 4B). The impaired 325 
migration capacity of the PHD2-deficient RAW cells could be mimicked by treating wt RAW 326 
cells with the PHD inhibitor DMOG or exposure to hypoxia (Fig. 4C). In line with the 327 
migration deficit, phagocytosis capacity was disturbed in the shPHD2 RAW cells and the 328 
PHD2 cKO BMDM (Fig. 4D). Comparable to the migration capacity the decreased 329 
phagocytosis could be mimicked in wt RAW cells by incubating the cells in hypoxia or by 330 
treatment with DMOG.  331 
Differential migration was not due to a modulated chemokine receptor expression since 332 
quantifying CCR2, CCR4, CCR5, CCR7 and CXCR4 RNA levels by RT-PCR after exposing 333 
wild type and PHD2 cKO BMDM to 20% O2 or 1% O2 did not reveal any difference between 334 
the cell types besides an upregulation of CCR1 in the PHD2 cKO cells (Fig. 4E). We however 335 
observed a significant upregulation of CCR1 and CCR5 and a slight upregulation of CXCR4 336 
in hypoxia, which is in line with the literature (17,18). Since the migration deficit was not due 337 
to a striking differential expression of chemokine receptors we further analyzed the impact of 338 
the metabolic alterations for the migratory and phagocytosis capacity. 339 
 340 
Regulation of PHD activity by PDK is critical for macrophage function  341 
To obtain insight into the importance of the altered PDK1 levels and PDH activity for the 342 
functional impairment of the PHD2-deficient macrophages, we treated cells with the PDK 343 
inhibitor DCA. DCA binds to PDK1 near the helix bundle in the N-terminal part. Bound DCA 344 
promotes local conformational changes that are communicated to both nucleotide-binding and 345 
lipoyl-binding pockets of PDK1, leading to the inactivation of kinase activity (19). DCA 346 
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treatment reestablished the decreased PDH activity in the shPHD2 RAW cells (Fig. 5A). In 347 
line with this shPHD2 and PHD2 cKO BMDM produced less lactate and demonstrated 348 
significantly increased ATP levels after DCA treatment (Fig. 5B and C). Reversal of the 349 
metabolic reprogramming after DCA treatment was also observed when analyzing the ECAR. 350 
Whereas the non-treated shPHD2 cells and PHD2 cKO BMDM had a significantly increased 351 
glycolysis and glycolytic capacity, this was significantly decreased in the DCA treated cells 352 
(Fig. 5D). Finally, we tested if DCA treatment is able to normalize the migration and 353 
phagocytosis deficit (Fig. 5E and F). Most interestingly, DCA treatment indeed was able to 354 
increase the impaired migration and phagocytosis capacity in the shPHD2 RAW and PHD2 355 
cKO cells to comparable levels of the wild type cells, strongly indicating that the metabolic 356 
programming via PDK1 per se is responsible for the functional alterations in consequence of 357 
downregulating PHD2 expression.   358 
PDK1 has been described to be a HIF target gene (7). In a previous report, we demonstrated 359 
that in PHD3 cKO BMDM HIF-1α is not stabilized in normoxia (12), which is in sharp 360 
contrast to the effect seen in the PHD2 cKO BMDM described here.  This was further 361 
supported by the fact, that HIF target genes including PDK1 were not significantly increased 362 
in PHD3 cKO BMDM other than PHD2 cKO or wt BMDMs in normoxia and hypoxia (Fig. 363 
6A). The genes identified in the gene array analysis (PHD2 cKO versus wt BMDM) were 364 
additionally compared to PHD3 regulated genes described earlier (12). Most interestingly just 365 
13 genes were found to be regulated in the PHD2 cKO as well as in the PHD3 cKO BMDM, 366 
indicating PHD isoform specific effects (Suppl. Table 3). In line ATP and lactate levels as 367 
well as accumulated migration difference were not altered in PHD3 cKO versus wt BMDM 368 
(Fig. 6B). To further analyze, if PHD2 mediates its effects via HIF-1α we generated dcKO 369 
mice. dcKO BMDM had a blunted response in RNA levels of the HIF target genes PHD3, 370 
Glut-1, PDK1, PDK1, Cox4.2 and LonP in hypoxia (Fig. 7A). The metabolic phenotype of 371 
the PHD2 cKO BMDM, i.e. decreased ATP levels, increased lactate levels, decreased OCR 372 
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and decreased migration was rescued in consequence of the HIF-1α knock out demonstrating 373 
that HIF-1 and PDK1 are the two main mediators for the PHD2-induced metabolic alterations 374 
(Fig. 7B-D).     375 
 376 
Discussion 377 
Macrophages are critical effector cells for innate immunity but also adaptive immune function 378 
by recruiting further cells to the inflamed tissue (20). To fulfill their functions macrophages 379 
need to efficiently migrate into the affected tissue and phagocytose invading pathogens or cell 380 
debris. Both characteristic features were severely impaired in the PHD2-deficient RAW cell 381 
line model as well as in the primary BMDM in our study. The impaired migration is in line 382 
with two previous studies analyzing the migratory capacity of PHD2-deficient peritoneal 383 
macrophages as well as shPHD2 RAW cells towards MCP-1 as a stimulus (21,22). Infiltrating 384 
inflammatory cells including macrophages play an important role in tissue remodeling after 385 
an insult. In line with this, LysM Cre PHD2fl/fl animals showed less macrophage infiltration in 386 
the aorta during hypertensive cardiovascular remodeling (21). This was associated with a 387 
protection from hypertension-induced left ventricular hypertrophy and reduced ejection 388 
fraction. The basis for the impaired macrophage migration, however, has not been analyzed in 389 
further depth so far.     390 
 Functionality of macrophages is significantly affected by their polarization as well as 391 
their metabolic phenotype. Macrophages can be generally classified into two major groups, 392 
i.e. the M1- (classically activated) and M2- (alternatively activated) macrophages (23). Both 393 
subgroups have specific functions for the inflammatory clearance of pathogens and tissue 394 
repair, respectively (24). HIF-1α and HIF-2α are known to affect macrophage polarization 395 
with a predominant role of HIF-1α for M1-macrophages and HIF-2α for M2-macrophages 396 
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(25). Since the PHD enzymes regulate HIFα stability it is tempting to speculate that inhibition 397 
of their enzymatic activity would also affect macrophage polarization. Characterization of 398 
resting as well as stimulated wt and PHD2 cKO macrophages, however, did not reveal any 399 
striking pattern, which would indicate a clear polarization. It is important to note that this 400 
observation is not in contrast with the study by Takeda et al, in which an M2-polarization has 401 
been described as a consequence of a PHD2 knock out (26). M2-polarization was observed in 402 
heterozygous but not homozygous PHD2-deficient macrophages by Takeda et al., which 403 
matches our observations with the homozygous PHD2-deficient macrophages.  404 
In stark contrast to the unaltered polarization, we found an influence of PHD2 on 405 
reprogramming of mitochondrial metabolism. This effect was mediated via PHD2 dependent 406 
regulation of PDK1 expression. This is in accordance with a recent report showing in 407 
livers/hepatocytes that PHD2 can regulate PDK1 (27). In line with higher levels of PDK1 and 408 
higher phosphorylation of its target PDH, the basal and stimulated oxygen consumption was 409 
significantly lower in the PHD2-deficient cells accompanied by an increased glycolytic 410 
capacity. PDK1 is a key regulatory enzyme in glucose metabolism. The PDH complex, which 411 
is regulated by PDK1, converts pyruvate produced from the glycolytic flux to acetyl-CoA. 412 
Pyruvate-derived acetyl-CoA then enters the TCA cycle that generates NADH that fuels the 413 
electron transport chain for oxidative phosphorylation. In hypoxia PDH activity is inhibited 414 
via PDK1 mediated phosphorylation, which induces the anaerobic glucose metabolic 415 
homeostasis under limited oxygen availability. This mechanism is widely used by tumor cells 416 
and is part of the so-called Warburg effect. Warburg described that unlike most normal 417 
tissues, cancer cells tend to “ferment” glucose into lactate even in the presence of sufficient 418 
oxygen to support mitochondrial oxidative phosphorylation (28). In case of immune cells the 419 
metabolic adaptation however is part of their physiological response. Innate immune cells like 420 
neutrophils likewise depend on anaerobic glycolysis for ATP production, which is also 421 
resembled by the fact, that they harbor only few mitochondria (29). In contrast macrophages 422 
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have comparable numbers of mitochondria like other body cells and thus a higher metabolic 423 
flexibility, which allows a quick metabolic switch from aerobic to anaerobic glycolysis. 424 
Hallmarks of anaerobic glycolysis are a reduced ATP production, increased lactate levels and 425 
decreased oxygen consumption (30). All three features were significantly altered in the 426 
PHD2-deficient macrophages indicating an anaerobic metabolic shift. Neutrophils and 427 
monocytes/macrophages fulfill their physiological function in severely hypoxic areas like 428 
inflammation or ischemia. Unlike short-lived neutrophils, macrophages survive longer in the 429 
body up to a maximum of several months. Compared to the oxygenated blood the pO2 in 430 
most tissues is significantly lower. Thus, compared to monocytes, macrophages need to be 431 
able to adapt to the hypoxic conditions, which reflect their physiological environment. In 432 
contrast, short lived neutrophils enter inflamed hypoxic tissue where they die quickly to fulfill 433 
their function. This is also reflected by the fact that in contrast to other cells, they die upon 434 
exposure to hypoxia. Most interestingly the metabolic phenotype observed in the shPHD2 435 
RAW cells and cKO BMDM mimicked the effects seen in wt cells in hypoxia. The metabolic 436 
adaptation thus might ensure function and viability of the cells as long as possible in the 437 
hypoxic conditions. A lower migration rate as a consequence helps to keep the cells in place 438 
until they are stimulated during the course of an acute inflammation.      439 
Recent evidence suggests an intricate link between metabolism and macrophage activation 440 
(31). To this end it becomes important to know what kind of metabolic changes occur after 441 
immune cell activation and if the altered metabolism per se can serve as a controller of the 442 
immunomodulatory functionality. Analyzing metabolic aspects as a consequence of blocking 443 
PHD2 thus might answer the question about what changes in the regulation of energy 444 
metabolism are necessary for macrophages and if these can be targeted to control innate 445 
immune function. In this regard our data clearly indicate that deleting PHD2 in macrophages 446 
is sufficient to drive an anaerobic glycolytic phenotype in normoxia and interferes with 447 
migration and phagocytosis. PHD enzyme activity can be inhibited with competitive 448 
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oxoglutarate analogues. Respective inhibitors are being developed to specifically interfere 449 
with the PHD/HIF signaling pathway (32). Short term treatment of wt macrophages with the 450 
PHD inhibitor DMOG or exposing the cells to hypoxia was indeed sufficient to mimic the 451 
metabolic features of the genetically modified macrophages. Moreover, the metabolic switch 452 
in the PHD2-deficient macrophages was readily reversible by inhibition of PDK1 453 
demonstrating that PHD2-mediated metabolic changes are not decretory. DCA treatment 454 
rescued all hallmarks of anaerobic glycolysis in the PHD2-deficient cells including the 455 
impaired functionality. A critical role of PDK1 for macrophage metabolism and function has 456 
been described earlier and is in line with our findings (33). Via altering PDK1 activity the 457 
cellular ATP levels as well as extracellular lactate levels are modulated. ATP as well as a 458 
lactate-enriched environment has been demonstrated to add to immunomodulatory functions 459 
by altering the migratory activity of defense cells (34,35). PDK1 as a molecule to target 460 
deregulated energy metabolism is an emerging strategy for cancer therapy (36). Redirection of 461 
glucose metabolism from glycolysis to oxidation, which reverses the Warburg effect, leads to 462 
inhibition of proliferation and induction of caspase-mediated apoptosis in tumor cells. Thus 463 
far, DCA is the most extensively studied PDK1 inhibitor; however, it has limited use for 464 
therapeutic purposes because of its low potency and high toxicity. PHD inhibitors on the other 465 
side have entered pre-clinical models and clinical trials and thus interfering with PHD2 466 
activity might serve as better strategy to influence immune functions via metabolic 467 
reprogramming (37).   468 
Taken collectively our study shows that while PHD2 is not required for macrophage 469 
polarization it controls macrophage metabolism and function. Mechanistically the balance 470 
between aerobic and anaerobic glycolysis is affected by PHD2 via the expression and activity 471 
of PDK1. This adds to our understanding of the functionality of macrophages in normoxia 472 
and hypoxia. In addition our finding might point to a possibility to specifically interfere with 473 
the inflammatory function of macrophages by inhibiting PHD2 activity.  474 
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Figure legends 604 
Fig. 1: PHD2 knock down RAW cells and PHD2 knock out (PHD2 cKO) BMDMs display 605 
increased PDK1 expression and activity. (A) wt RAW and shPHD2 knock down cells as well 606 
as wt BMDM and PHD2 cKO macrophages were incubated for 24 hrs at 20% or 1% O2. RNA 607 
levels of the indicated genes were analyzed by qRT-PCR. RNA levels of wt RAW and wt 608 
BMDM cells were set to one. Fold change of the RNA levels of shPHD2 or the PHD2 cKO 609 
BMDM or wt cells in hypoxia of the indicated genes compared to the wt cells in normoxia 610 
was analyzed. n = 3-6 independent samples per condition. (B) Annexin V (AV) single-611 
positive cells were analyzed in wt BMDM and PHD2 cKO macrophages with and without 612 
treatment with 1 mM DMOG for 24 hrs. (C) HIF-1α, HIF-2α, PHD2 and β-actin protein 613 
levels of wt RAW and shPHD2 as well as wt BMDM and PHD2 cKO macrophages in 614 
normoxia (20% O2) or hypoxia (1% O2 for 24 hrs). (D) phospho-PDH, total PDH, PDK and 615 
β-actin protein levels of wt RAW and shPHD2 cells as well as wt BMDM and PHD2 cKO 616 
macrophages in normoxia (20% O2) or hypoxia (1% O2 for 24 hrs). (E) PDH activity in wt 617 
RAW, shPHD2 RAW cells and wt RAW cells treated with 1 mM DMOG for 24 hrs in 618 
normoxia or hypoxia (1% O2 for 24 hrs). n = 6 independent samples per condition. mean ± 619 
SEM, * p<0.05. 620 
Fig. 2: As a consequence of a reduction of PHD2 expression macrophages shift their 621 
metabolism towards anaerobic glycolysis. (A) wt RAW, shPHD2 RAW, wt BMDM and 622 
PHD2 cKO cells or wt RAW cells treated with 1 mM DMOG for 24 hrs were tested for their 623 
oxygen consumption rate (OCR) after addition of oligomycin, FCCP as well as rotenone and 624 
antimycin A (Rot + AA). n = 6 (RAW) and n = 10 (BMDM) independent samples per 625 
condition. (B) Basal respiration and maximum respiration were analyzed in wt RAW, 626 
shPHD2 RAW, wt BMDM and PHD2 cKO cells based on the experiments shown in A. OCR 627 
after addition of Rot + AA was subtracted from the OCR after addition of oligomycin and 628 
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FCCP to obtain basal respiration and maximum respiration values, respectively. (C) 629 
Extracellular acidification rate (ECAR) was determined in wt RAW and shPHD2 RAW as 630 
well as (D) wt BMDM and PHD2 cKO cells or wt RAW cells treated with 1 mM DMOG for 631 
24 hrs after addition of glucose, oligomycine and 2-desoxy glucose (2-DG). n = 7 independent 632 
samples per condition. (E, F) Glycolysis and anaerobic glycolytic capacity were analyzed 633 
based on the experiments shown in C and D. The ECAR after addition of 2-DG was 634 
subtracted from the ECAR after addition of glucose or oligomycine to obtain glycolysis and 635 
glycolytic capacity values, respectively. (G) Lactate levels were determined in the supernatant 636 
of wt RAW, shPHD2 RAW, wt BMDM and PHD2 cKO cells after incubation of the cells at 637 
the indicated conditions. n = 4 independent samples per condition. mean ± SEM, * p<0.05. 638 
(H) Lactate levels were determined in the supernatant of wt BMDM and cKO cells after 639 
incubation of the cells at 20% O2, 1% O2 with or without addition of glucose in the cell 640 
culture medium. Cells were incubated for 24 hrs in the respective cell culture medium, n = 4 641 
independent samples per condition. 642 
Fig. 3: Decreased ATP levels and unaltered polarization in PHD2 deficient macrophages. 643 
(A) wt RAW, shPHD2 RAW, wt BMDM and PHD2 cKO cells were incubated at 20% O2 or 644 
1% O2 for 24 hrs. Subsequently intracellular ATP levels were determined. n = 6 independent 645 
samples per condition. Right panel: wt RAW cells were incubated for the indicated times with 646 
1 mM DMOG and ATP levels were determined. n = 6-7 independent samples per condition. 647 
(B) RNA levels of M1- and M2-markers in resting wt BMDM and cKO cells or (C) after 648 
stimulation with IL-4 (20 nM) or LPS (100 ng/ml) and IFN (20 nM) for 24 hrs. (D) RNA 649 
levels of M1 and M2-markers in resting wt BMDM and PHD2 cKO cells were analyzed after 650 
treatment of the cells with 1mM DMOG for 24 hrs. Fold change of the RNA levels of DMOG 651 
treated wt or cKO BMDM of the indicated genes compared to the non-treated cells was 652 
analyzed. n = 3-6 independent samples per condition. mean ± SEM, * p<0.05. 653 
29 
 
Fig. 4: A reduction of PHD2 expression in RAW cells or BMDMs results in a defect in 654 
macrophage migration and phagocytosis. (A)  wt RAW, shPHD2 RAW, wt BMDM and 655 
PHD2 cKO cells were tested for their migration capacity in Boyden chambers using FCS or 656 
conditioned medium of MDA-MB231 cells as stimulants. n = 4 (RAW cells), n = 4 (BMDM) 657 
independent samples. (B) The accumulated migration distance over 6 hrs of wt RAW, 658 
shPHD2 RAW, wt BMDM and PHD2 cKO cells was tested in single cell migration 659 
experiments using FCS or conditioned medium of MDA-MB231 cells as stimulants. n = 59-660 
64 cells per condition (RAW cells), n = 51-71 cells per conditions (BMDM cells). (C) wt 661 
RAW cells were incubated at 20% O2 ± 1 mM DMOG or 1% O2 for 6 hrs. The accumulated 662 
migration distance was tested in single cell migration experiments using FCS or conditioned 663 
medium of MDA-MB231 cells as stimulants. For cells analyzed at 1% O2 the hypoxic 664 
conditions were kept during the single cell migration experiments without reoxygenation. n = 665 
50-53 cells per condition. (D) wt RAW, shPHD2 RAW, wt BMDM and PHD2 cKO cells 666 
were incubated at 20% O2 ± 1 mM DMOG or 1% O2 in total for 20 hrs. Subsequently, the 667 
capacity of the cells to phagocytose labeled beads was analyzed. Fluorescence beads were 668 
added to the cells for 4 hrs without reoxygenation. n = 5 independent samples per condition. 669 
mean ± SEM, * p<0.05. (E) RNA levels of chemokine receptors in resting wt BMDM and 670 
PHD2 cKO cells after incubation in normoxia or hypoxia (1% O2) for 24 hrs. Fold change of 671 
the RNA levels in the PHD2 cKO BMDM of the indicated genes compared to the wt cells in 672 
normoxia was analyzed. n = 3 independent samples per condition. mean ± SEM. *p<0.05. 673 
Fig. 5: Inhibition of PDK1 by dichloroacetate (DCA) reverses the metabolic phenotype and 674 
the migration defect in PHD2-deficient macrophages. (A) PDH activity was determined in 675 
lysates of wt RAW, shPHD2 RAW cells after incubation of the cells ± 5 mM DCA for 24 hrs. 676 
n = 6 independent samples per condition. Lactate levels in the supernatants and intracellular 677 
ATP levels of wt RAW and shPHD2 RAW (B) as well as wt BMDM and cKO macrophages 678 
(C) after incubation of the cells ± 5 mM DCA for 24 hrs.  (D) Glycolysis and glycolytic 679 
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capacity were analyzed in wt RAW, shPHD2 RAW, wt BMDM and PHD2 cKO after 680 
incubating the cells ± 5 mM DCA for 24 hrs. n = 6-10 independent samples per condition. (E) 681 
The accumulated migration distance over 6 hrs of wt RAW and shPHD2 RAW cells after 682 
incubation of the cells ± 5 mM DCA for 24 hrs was determined in single cell migration 683 
experiments using FCS or conditioned medium of MDA-MB231 cells as stimulants. n = at 684 
least 20 cells per condition. (F) wt RAW, shPHD2 RAW, wt BMDM and PHD2 cKO cells 685 
were incubated ± 5 mM DCA for 24 hrs. Subsequently, the capacity of the cells to 686 
phagocytose labeled beads was analyzed. n = 5-8 independent samples per condition. mean ± 687 
SEM, * p<0.05. 688 
Fig. 6: No metabolic phenotype in PHD3-deficient macrophages. (A) wt BMDM and PHD3 689 
cKO macrophages were incubated for 24 hrs at 20% or 1% O2. RNA levels of the indicated 690 
genes were analyzed by qRT-PCR. RNA levels of wt BMDM cells were set to one. Fold 691 
change of the RNA levels of PHD3 cKO BMDM or wt cells in hypoxia of the indicated genes 692 
compared to the wt cells in normoxia was analyzed. n = 3 independent samples per condition. 693 
(B) ATP (n = 5 independent samples) and lactate levels (n = 4 independent samples) as well 694 
as accumulated migration distance were determined in wt BMDM and PHD3 cKO 695 
macrophages. 696 
Fig. 7: HIF-1α mediates the metabolic alterations in PHD2-deficient macrophages. (A) wt 697 
BMDM and dcKO macrophages were incubated for 24 hrs at 20% or 1% O2. RNA levels of 698 
the indicated genes were analyzed by qRT-PCR. RNA levels of wt BMDM cells were set to 699 
one. Fold change of the RNA levels of dcKO BMDM or wt cells in hypoxia of the indicated 700 
genes compared to the wt cells in normoxia was analyzed. n = 3 independent samples per 701 
condition. mean ± SEM, * p<0.05 compared to wt 20% O2, # p<0.05 compared to wt 1% O2. 702 
(B) Intracellular ATP levels were determined in wt BMDM, PHD2 cKO and dcKO cells after 703 
incubation for 24 hrs in 20% O2 or 1% O2. (C) Oxygen consumption rate (OCR) and lactate in 704 
31 
 
the supernatants of wt BMDM PHD2 cKO and dcKO cells were analyzed. (D) The 705 
accumulated migration distance over 6 hrs of wt BMDM, PHD2 cKO and dcKO cells  was 706 
determined in single cell migration experiments using FCS or conditioned medium of MDA-707 
MB231 cells as stimulants. n = at least 20 cells per condition.  mean ± SEM, * p<0.05. 708 
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